HÉCTOR JOSÉ
BUENO ZAMORA

Profesor asociado de Ciencias de la Salud

Foto de HÉCTOR JOSÉ

Foto de Duke Clinical Research Institute

Duke Clinical Research Institute

Durham, Estados Unidos

Publications en collaboration avec des chercheurs de Duke Clinical Research Institute (5)

2023

External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry
International Journal of Cardiology, Vol. 370, pp. 51-57

2020

Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis
Thrombosis Research, Vol. 195, pp. 128-135

2017

Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
The Lancet, Vol. 389, Núm. 10081, pp. 1799-1808

2007

Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: Benefit and harm in different age subgroups
Heart, Vol. 93, Núm. 4, pp. 450-455

2006

Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes
European Heart Journal, Vol. 27, Núm. 24, pp. 2956-2961